Key Market Indicators
Swedish Beta Blocking Medicine sales are projected to drop 0.7% year on year to reach $50 million by 2026. The market has grown 3.1% year on year since 2005. In 2021, Sweden was ranked 9th with $53.57 million in sales. Greece overtook Sweden to take the lead with $53.57 million. Italy, Canada and Australia followed as the second, third and fourth largest markets, respectively.
